Evaluating quality of life of non-small cell lung cancer in the elderly treated with chemotherapy or molecular targeted therapy

Evaluating quality of life of non-small cell lung cancer in the elderly treated with chemotherapy or molecular targeted therapy - Evaluating quality of life of non-small cell lung cancer in the elderly treated with chemotherapy or molecular targeted therapy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000005267

Enrollment

Registered

2011-03-17

Start date

2009-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-small cell lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Histology/cytology-proven non-small cell lung cancer, age of 70 years or over 2)ECOG performance status of 0-2 3)Acquisition of written informed consent

Exclusion criteria

Exclusion criteria: 1)Patients with dementia 2)Those judged to be not suitable by the attending physician

Design outcomes

Primary

Measure	Time frame
QOL evaluation (FACT-L)	—

Countries

Japan

Outcome results